Up-regulated PXDNL and LINC02038 in the high-risk score group synergistically construct immunosuppressive microenvironment and promote tumor progression by impairing the cytotoxic T lymphocytes (CTLs) and inhibiting NK cell function. The gene discussed is PXDNL; the disease is neoplasm.